Product Information
LIDOCAINE 2% VISCOUS SOLN is a generic product labeled by Advagen Pharma Ltd., priced at $0.0825 per ML under NDC 72888012526. Its NADAC has been published 162 times since Aug 30, 2023.
FDA first approved this application on Mar 28, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
20 mg/mL
Manufacturer
Advagen Pharma Ltd.NDC
72888012526
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216780FDA Approved
3/28/2023
TE Code
AT
On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 2% VISCOUS SOLN has been published 162 times since Aug 30, 2023, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0825 per ML |
|---|---|
| All-time high | $0.1070 (May 14, 2025) |
| All-time low | $0.0792 (Apr 22, 2026) |
| 52-week high | $0.0989 |
| 52-week low | $0.0792 |
| Median price | $0.0893 |
| Average price | $0.0910 |
| Largest weekly change | -14.2% (Nov 20, 2024) |
| Weeks tracked | 162 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 2% VISCOUS SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 2% VISCOUS SOLN, manufactured by Advagen Pharma Ltd., is $0.0825 per ML (NDC 72888012526), effective Sep 30, 2026.
How has the price of LIDOCAINE 2% VISCOUS SOLN changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 2% VISCOUS SOLN has declined 11.0%. It has been tracked across 162 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 2% VISCOUS SOLN?
Since Aug 30, 2023, the NADAC for LIDOCAINE 2% VISCOUS SOLN has ranged from a low of $0.0792 (Apr 22, 2026) to a high of $0.1070 (May 14, 2025), with a median of $0.0893 per ML.
Are there cheaper alternatives to LIDOCAINE 2% VISCOUS SOLN?
No other NADAC-published product currently shares the active ingredient and strength of LIDOCAINE 2% VISCOUS SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LIDOCAINE 2% VISCOUS SOLN?
LIDOCAINE 2% VISCOUS SOLN (NDC 72888012526) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.